# Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers

> **NCT01147055** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** crizotinib
- **DRUG:** rifampin
- **DRUG:** crizotinib

## Key facts

- **NCT ID:** NCT01147055
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2011-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147055, "Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01147055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*